Значение гаплотипов ADRB2 при трудноконтролируемой бронхиальной астме
This study aimed to evaluate the clinical and prognostic significance of ADRB2 haplotypes in adults with difficult-to-control asthma. A total of 128 patients aged 26–64 years who were receiving inhaled corticosteroid/long-acting β2-agonist (ICS/LABA) therapy at treatment steps 4–5 were included. The ADRB2 variants rs1042713 and rs1042714 were genotyped using real-time polymerase chain reaction (PCR). The frequency of the Arg16/Gln27 haplotype was 37.5%. Compared with noncarriers, carriers of this haplotype exhibited a smaller increase in forced expiratory volume in one second (FEV₁) following salbutamol administration (8.6 ± 3.2% vs. 13.2 ± 4.1%; p < 0.01), a shorter six-minute walk distance, and higher levels of high-sensitivity C-reactive protein (hs-CRP), fibrinogen, and blood eosinophils. They also demonstrated poorer asthma control, as assessed by the Asthma Control Questionnaire-6 (ACQ-6), and lower quality of life, as measured by the Asthma Quality of Life Questionnaire (AQLQ). During the 12-month follow-up period, haplotype carriers experienced more frequent exacerbations (1.9 ± 0.8 vs. 1.2 ± 0.6 events per year; p = 0.015). In multivariable analysis, the Arg16/Gln27 haplotype remained independently associated with higher odds of exacerbations (odds ratio [OR], 1.27; 95% confidence interval [CI], 1.03–1.58). These findings suggest that the Arg16/Gln27 haplotype may be a relevant genetic marker for consideration in multifactorial risk stratification among patients with difficult-to-control asthma.
Сведения
- Опубликовано
- 2026 · Т. 5, № 5, С. 463-473
- Язык
- Русский
- ISSN
- 2181-3663
- Издатель
- inScience LLC